Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H26N2O4 |
| Molecular Weight | 370.4421 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)[C@H](O)CN2CCN(CC2)C3=CC=CC=CC3=O
InChI
InChIKey=SGEKLKJQLHJVDK-LJQANCHMSA-N
InChI=1S/C21H26N2O4/c1-26-20-9-8-16(14-21(20)27-2)19(25)15-22-10-12-23(13-11-22)17-6-4-3-5-7-18(17)24/h3-9,14,19,25H,10-13,15H2,1-2H3/t19-/m1/s1
| Molecular Formula | C21H26N2O4 |
| Molecular Weight | 370.4421 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ciladopa, is a troponylpiperazine derivative and dopamine agonist that has been shown to influence dopaminergic mechanisms in animals. Preclinical pharmacological studies have suggested that it has antiparkinsonian activity similar to that of bromocriptine but without many of the troublesome side effects. Unfortunately in some clinical trials no significant differences was found among the treatment groups and placebo.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3774130 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3606037
15 mg twice daily for 8 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:26 GMT 2025
by
admin
on
Mon Mar 31 18:22:26 GMT 2025
|
| Record UNII |
D09L486R3J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C045964
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
SUB06262MIG
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
DTXSID101024642
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
Ciladopa
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
D09L486R3J
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110793
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
C79568
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
5559
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
100000081291
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
133371
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY | |||
|
80109-27-9
Created by
admin on Mon Mar 31 18:22:26 GMT 2025 , Edited by admin on Mon Mar 31 18:22:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |